| Active Pharmaceutical Ingredients (API) | Manufacture and supply of bulk drug substances for generic and specialty pharmaceutical customers. | Regulatory approvals, diversified global customer base, technology collaborations. | Pharmaceutical manufacturers globally (B2B). | Specialty APIs and captive consumption products. | 1200 | 57 | Sales of APIs primarily through exports to global pharmaceutical companies. | Contract sales based on volume agreements and market prices. | Global generic demand, capacity expansions, API plant upgrades, partnerships. | |
| Formulations and Specialties Division | Generic drug formulations across therapeutic areas including women's health, dermatology, cardiology, and nephrology. | Strong R&D, regulatory certifications, diversified product portfolio. | Healthcare providers, distributors, and institutional buyers worldwide (B2B/B2C). | Specialty products and newly launched formulations. | 911 | 43 | Sales and marketing of finished drug products primarily via subsidiaries and export channels. | Product sales, distribution agreements, subscription to licenses. | New product launches, geographic expansion, market acquisitions, IP portfolio. | |
